BREAKING
Fiserv (FISV) Earnings: 4Q25 Key Numbers 1 hour ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 2 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 14 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 14 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 17 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 19 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 21 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 23 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 1 hour ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 2 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 14 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 14 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 17 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 19 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 21 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 23 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago
ADVERTISEMENT
AlphaGraphs

Infographic: Highlights of Canopy Growth’s (CGC) Q3 2023 earnings

Cannabis producer Canopy Growth Corporation (NASDAQ: CGC) reported a wider net loss for the third quarter of 2023, hurt by a 28% fall in revenues. In the three months that ended December 2022, the net loss widened to C$261.6 million or C$0.54 per share from C$108.9 million or C$0.28 per share in the same period […]

$CGC February 13, 2023 1 min read

Cannabis producer Canopy Growth Corporation (NASDAQ: CGC) reported a wider net loss for the third quarter of 2023, hurt by a 28% fall in revenues.

Canopy Growth Q3 2023 earnings infographic

In the three months that ended December 2022, the net loss widened to C$261.6 million or C$0.54 per share from C$108.9 million or C$0.28 per share in the same period of the previous year. The bottom line was negatively impacted primarily by a decrease in the number of payroll subsidies received from the Canadian government pursuant to a COVID-19 relief program, and the divestiture of lower gross margins in the BioSteel business segment.

Third-quarter revenues decreased 28% annually to C$101.2 million, reflecting weakness in all the key operating segments.

ADVERTISEMENT